Karen Winterhalter joins Burson-Marsteller as Leader of the European Healthcare Practice
Press releases • 30th April 2008
London, 30 April, 2008 – Burson-Marsteller, a leading global public relations and public affairs firm, today announced that Karen Winterhalter has been appointed Leader of the European Healthcare Practice. She will be based in Burson-Marsteller’s London office and will assume her new role on 6 May.
Karen brings extensive healthcare communications experience to the role of European Practice Leader, having owned and managed Onyx Health Ltd., a boutique healthcare communications firm which she established four and half years ago. Prior to establishing Onyx, Karen held the position of European Director of Healthcare with Weber Shandwick. Karen writes her own blog and brings significant insight into on-line healthcare communications.
“This is a really exciting opportunity, especially given the serious investment that Burson-Marsteller is making in the healthcare sector on a global basis, as evidenced by the recent appointment of a Global Practice Chair, Gail Cohen. My focus will be to grow Burson-Marsteller’s pan-European network capabilities as well as strengthen the existing business in key markets across Europe,” said Karen.
“We are extremely pleased to have Karen leading one of our core European practices. She brings numerous strengths to the job, having both a medical background and having founded and grown her own healthcare business, Onyx Health. Karen has also been in a similar pan-European role before and, importantly for Burson-Marsteller, has a strong digital focus in her work. Her appointment is part of our commitment to investing in our thirteen European practices,” commented Jeremy Galbraith, CEO Europe, Middle East and Africa.
Search this website
More B-M Talk
Burson-Marsteller accepts no responsibility for external links. Content of websites which are linked through B-M Talk is solely provided by the website owner.
(B-M Talk is updated automatically once per hour, 24 hours per day.)

Leave a Reply